BWC Workshop Emerging infectious diseases, bioterrorism and - - PowerPoint PPT Presentation

bwc workshop
SMART_READER_LITE
LIVE PREVIEW

BWC Workshop Emerging infectious diseases, bioterrorism and - - PowerPoint PPT Presentation

BWC Workshop Emerging infectious diseases, bioterrorism and emerging biotechnology Diane DiEuliis, Ph.D. Center for the Study of Weapons of Mass Destruction National Defense University July 7, 2016 Center for the Study of Center for


slide-1
SLIDE 1

1 Center for the Study of Weapons of Mass Destruction 1 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

BWC Workshop

“Emerging infectious diseases, bioterrorism and emerging biotechnology”

Diane DiEuliis, Ph.D. Center for the Study of Weapons of Mass Destruction National Defense University July 7, 2016

slide-2
SLIDE 2

2 Center for the Study of Weapons of Mass Destruction 2 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis
slide-3
SLIDE 3

3 Center for the Study of Weapons of Mass Destruction 3 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Newly Emerging Re-Emerging/Surging “Deliberately Emerging” (Fauci, 2016)

slide-4
SLIDE 4

4 Center for the Study of Weapons of Mass Destruction 4 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Humans and the Environment

  • Development/land use: increases in

human/zoonotic boundaries **75% of EIDs are zoonotic

  • Travel/commerce: disease travels with people
  • Human behavior
  • Presence/absence of public health infrastructure

Germs adapt and change naturally; bioterror agents may be altered in similar or dissimilar ways.

slide-5
SLIDE 5

5 Center for the Study of Weapons of Mass Destruction 5 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Some outbreaks of 2015-2016

  • Measles
  • Drug resistant TB

and malaria

  • H7N9 flu
  • MERS CoV
  • Chikungunya
  • Ebola
  • Cholera
  • Dengue
  • Zika
  • Yellow fever
  • Antibiotic resistant

bacterial strains

Outbreaks may be select or non-select agents

slide-6
SLIDE 6

6 Center for the Study of Weapons of Mass Destruction

Surveillance and response

EID

  • Early detection
  • Diagnostics
  • Epidemiology
  • Countermeasure

Development

  • Countermeasure dispensing
  • Communication/social

mitigation Bioterrorism

  • Early detection
  • Diagnostics
  • Epidemiology
  • Countermeasure

development

  • Countermeasure dispensing
  • Communication/social

mitigation

  • Attribution

There is high overlap in capabilities needed to respond. Emerging biotech creates opportunities and challenges)

slide-7
SLIDE 7

7 Center for the Study of Weapons of Mass Destruction 7 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Role of emerging technology

  • Advances in bioinformatics: sequences can

be shared more rapidly than physical samples;

  • Diagnostics, animal models are advanced

and/or enabled by new genetic tools such as CRISPR/Cas

  • Vector control: better ways to sample vector

populations for disease; eradication of disease from vector populations?

slide-8
SLIDE 8

8 Center for the Study of Weapons of Mass Destruction 8 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

CRISPR and emerging capabilities are changing the BW landscape

  • Ability to edit genes is getting easier, cheaper, more

precise and open to wider range of actors = creation of BW (human, plant, animal, environmental) is enabled;

  • Novel threats enabled?
  • Will “bio-based” commodities become new BW

targets?

  • Challenges for list-based regimes for control and

mitigation;

  • Attribution is challenged.

CRISPR = “Clustered Regularly Interspaced Short Palindromic Repeats”

slide-9
SLIDE 9

9 Center for the Study of Weapons of Mass Destruction 9 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Additional Observations

  • The WMD paradigm is not sufficient: emerging

biological threats may have strategic significance without creating “mass destruction”; ability to incite fear and instability in society through perpetrated disease.

  • Emerging technologies could enable the specific

genetic targeting of individuals or groups of people in 5-10 years.

  • “Human performance” enablers can alter military

competitiveness. Should we re-evaluate definition of a biological WMD?

slide-10
SLIDE 10

10 Center for the Study of Weapons of Mass Destruction 10 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Health Security and Nation Stability

  • Ensuring nations develop strong public health

capacity is required for response to both EIDs and bioterror;

  • Health capacity contributes to overall nation

stability;

– Syria exemplifies;

  • EIDs threaten health of deployed forces and

global health security as much or more as bioterror (e.g. drug resistant malaria)

slide-11
SLIDE 11

11 Center for the Study of Weapons of Mass Destruction 11 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Thank you

  • “The international public health and emergency response

architecture is in the midst of significant change right now. It is critical that the steps we take to strengthen article VII are integrated into the new architecture that emerges….efforts to assist States Parties in building their public health and response capabilities are not ‘assistance” in the sense of Article VII – but in the event of biological weapons use, may be even more valuable than response efforts after the fact.” - Amb. Wood

  • Questions?
slide-12
SLIDE 12

12 Center for the Study of Weapons of Mass Destruction 12 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis
  • Extra slides
slide-13
SLIDE 13

13 Center for the Study of Weapons of Mass Destruction 13 Center for the Study of Weapons of Mass Destruction UNCLASSIFIED

  • D. DiEuliis

Why current biosecurity policies fall short:

  • Rapid pace of biotechnology

– far outpaces policy development timelines; – Will stymie list-based means of controls

  • Capabilities are accessible to wider range of actors

– emerging biotechnology is becoming ‘democratized’ – growth of DIY biology lowers barriers to entry

  • Gene editing tools accessible, inexpensive, efficient;
  • Enabling IT: DNA is increasingly easy to engineer

through standards and bioinformatics